![Chemical structure of Benzenesulfonamide, N-[(butylamino)carbonyl]-4-methyl-, CAS 64-77-7](https://api.angenesci.com/structure/3337/64-77-7.png)
无数据
无数据
无数据
| CAS Number | 64-77-7 |
| Catalog Number | AG00E9I8(AGN-PC-09QZS4) |
| Chemical Name | Benzenesulfonamide, N-[(butylamino)carbonyl]-4-methyl- |
| EC Number | 200-594-3 |
| IUPAC Name | 1-butyl-3-(4-methylphenyl)sulfonylurea |
| InChI | InChI=1S/C12H18N2O3S/c1-3-4-9-13-12(15)14-18(16,17)11-7-5-10(2)6-8-11/h5-8H,3-4,9H2,1-2H3,(H2,13,14,15) |
| InChI Key | JLRGJRBPOGGCBT-UHFFFAOYSA-N |
| MDL Number | MFCD00027169 |
| Molecular Formula | C12H18N2O3S |
| Molecular Weight | 270.3479 |
| SMILES | S(=O)(=O)(NC(=O)NCCCC)c1ccc(cc1)C |
| UNII | 982XCM1FOI |
| Synonyms | Apo-Tolbutamide,
Artosin,
Diabetol,
Diaval,
Dolipol,
Orabet,
Orinase,
Rastinon,
Tolbutamid R.A.N.,
Tolbutamide,
tolbutamide,
64-77-7,
Orinase,
Artosin,
1-Butyl-3-tosylurea,
Tolbutamid,
Aglicid,
Arkozal,
Diabetol,
Dolipol,
Rastinon,
Tolumid,
Diaben,
Orabet,
Willbutamide,
Butamide,
Diabetamid,
Diabuton,
Diasulfon,
Dirastan,
Glyconon,
Ipoglicone,
Pramidex,
Tolbusal,
Artozin,
Butamid,
Drabet,
Mobenol,
Oralin,
Orezan,
Orinaz,
Oterben,
Toluina,
Toluvan,
Tolylsulfonylbutylurea,
Sk-tolbutamide,
1-Butyl-3-(p-tolylsulfonyl)urea,
Tolbutamida,
Tolbutamidum,
N-n-Butyl-N'-tosylurea,
N-Butyl-N'-(p-tolylsulfonyl)urea,
1-Butyl-3-(p-methylphenylsulfonyl)urea,
1-p-Toluenesulfonyl-3-butylurea,
Beglucin,
Butamidum,
Diabesan,
Tarasina,
Tolbutone,
Arcosal,
Tolbet,
N-(Butylcarbamoyl)-4-methylbenzenesulfonamide,
3-(p-Tolyl-4-sulfonyl)-1-butylurea,
HLS 831,
N-Butyl-N'-p-toluenesulfonylurea,
N-(4-Methylphenylsulfonyl)-N'-butylurea,
N-Butyl-N'-(4-methylphenylsulfonyl)urea,
Orinase (TN),
N-(4-Methylbenzenesulfonyl)-N'-butylurea,
Benzenesulfonamide, N-[(butylamino)carbonyl]-4-methyl-,
Urea, 1-butyl-3-(p-tolylsulfonyl)-,
N-(p-Tolylsulfonyl)-N'-butylcarbamide,
N-(Sulfonyl-p-methylbenzene)-N'-N-butylurea,
Tolbutamidum [INN-Latin],
Tolbutamida [INN-Spanish],
NCI-C01763,
N-4-Methylbenzolsulfonyl-N-butylurea,
D 860,
3-butyl-1-(4-methylbenzenesulfonyl)urea,
N-Butyl-N'-toluene-p-sulfonylurea,
UNII-982XCM1FOI,
MFCD00027169,
CCRIS 592,
N-4-(Methylbenzolsulfonyl)-n-butylurea,
1-Butyl-3-(4-methylphenylsulfonyl)urea,
N-[(butylamino)carbonyl]-4-methylbenzenesulfonamide,
C12H18N2O3S,
HSDB 3393,
EINECS 200-594-3,
NSC 23813,
U 2043,
3-[p-Tolyl-4-sulfonyl]-1-butylurea,
CHEMBL782,
1-butyl-3-(4-methylphenyl)sulfonylurea,
BRN 1984428,
982XCM1FOI,
N-(p-Methylbenzenesulfonyl)-N'-butylurea,
Benzenesulfonamide, N-((butylamino)carbonyl)-4-methyl-,
N-(Sulfonyl-p-methylbenzene)-N'-butylurea,
MLS000028399,
CHEBI:27999,
JLRGJRBPOGGCBT-UHFFFAOYSA-N,
N-((Butylamino)carbonyl)-4-methylbenzenesulfonamide,
CAS-64-77-7,
NCGC00015999-10,
SMR000058363,
Apo-Tolbutamide,
3-butyl-1-[(4-methylbenzene)sulfonyl]urea,
DSSTox_CID_1359,
1-BUTYL-3-(4-METHYLBENZENESULFONYL)UREA,
DSSTox_RID_76106,
DSSTox_GSID_21359,
toluran,
Oramide,
Restinon,
Tolumide,
Novo-Butamide,
Tol-Tab,
Tolbutamide [INN:BAN:JAN],
TOLBUTAMIDE USP,
SR-01000003059,
(butylamino)-N-[(4-methylphenyl)sulfonyl]carboxamide,
3-(p-tolylsulfonyl)-1-butylurea,
Tolbutamide [USP:INN:BAN:JAN],
Prestwick_471,
N-(p-tolylsulfonyl)-N'-n-butylurea,
1-Butyl-3-(para-tolylsulfonyl) urea,
PubChem18102,
Spectrum_000447,
Opera_ID_112,
AC1L1KHP,
Prestwick0_000190,
Prestwick1_000190,
Prestwick2_000190,
Prestwick3_000190,
Spectrum2_001210,
Spectrum3_000599,
Spectrum4_000358,
Spectrum5_001272,
Lopac-T-0891,
N-n-Butyl-N''-tosylurea,
WLN: 4MVMSWR D1,
T 0891,
AC1Q2X3T,
NCIOpen2_009592,
BIDD:PXR0179,
CBiol_001920,
Lopac0_001154,
SCHEMBL15918,
BSPBio_000119,
BSPBio_001507,
BSPBio_002078,
KBioGR_000227,
KBioGR_000795,
KBioGR_002275,
KBioSS_000227,
KBioSS_000927,
KBioSS_002276,
4-11-00-00396 (Beilstein Handbook Reference),
MLS001148399,
MLS002152944,
Toluina|||Tolumid|||Orinase,
DivK1c_000341,
SPECTRUM1500581,
SPBio_001000,
SPBio_002040,
BPBio1_000131,
GTPL6848,
Tolbutamide (JP17/USP/INN),
Tolbutamide, analytical standard,
DTXSID8021359,
HMS501B03,
KBio1_000341,
KBio2_000227,
KBio2_000927,
KBio2_002275,
KBio2_002795,
KBio2_003495,
KBio2_004843,
KBio2_005363,
KBio2_006063,
KBio2_007411,
KBio3_000453,
KBio3_000454,
KBio3_001578,
KBio3_002755,
KS-00000XIN,
cMAP_000008,
NINDS_000341,
1-Butyl-3-(p-tolylsulfonoyl)urea,
Bio1_000206,
Bio1_000695,
Bio1_001184,
Bio2_000227,
Bio2_000707,
HMS1361L09,
HMS1568F21,
HMS1791L09,
HMS1989L09,
HMS2089C17,
HMS2092M21,
HMS2095F21,
HMS2232H16,
HMS3259A08,
HMS3263H09,
HMS3402L09,
HMS3651N03,
HMS3712F21,
Pharmakon1600-01500581,
BCP09192,
HY-B0401,
NSC23813,
ZINC1530703,
1-n-Butyl-3-(p-tolylsulfonyl)urea,
N-Butyl-N''-(p-tolylsulfonyl)urea,
Tox21_110279,
Tox21_201612,
Tox21_302795,
Tox21_501154,
BDBM50027886,
CCG-39141,
LS-278,
NSC-23813,
NSC757354,
s2443,
SBB058188,
1-Butyl-3-(para-tolylsulfonyl)-urea,
AKOS015894999,
Tox21_110279_1,
1-(p-toluenesulfonyl)-3-n-butyl-urea,
CS-2500,
DB01124,
LP01154,
MCULE-9720356859,
NC00543,
NE30724,
NSC-757354,
Tolbutamide 1.0 mg/ml in Acetonitrile,
IDI1_000341,
IDI1_033977,
N-(n-Butyl)-N'-p-toluene-sulfonylurea,
NCGC00015999-01,
NCGC00015999-02,
NCGC00015999-03,
NCGC00015999-04,
NCGC00015999-05,
NCGC00015999-06,
NCGC00015999-07,
NCGC00015999-08,
NCGC00015999-09,
NCGC00015999-11,
NCGC00015999-12,
NCGC00015999-13,
NCGC00015999-14,
NCGC00015999-15,
NCGC00015999-16,
NCGC00015999-17,
NCGC00015999-19,
NCGC00022721-03,
NCGC00022721-04,
NCGC00022721-05,
NCGC00022721-06,
NCGC00022721-07,
NCGC00022721-08,
NCGC00022721-09,
NCGC00022721-10,
NCGC00256548-01,
NCGC00259161-01,
NCGC00261839-01,
AC-12490,
AJ-26683,
AK115688,
AN-16594,
AS-14136,
CPD000058363,
K045,
SAM002554936,
SC-17768,
N-(4-Methylphenylsulfonyl)-N''-butylurea,
N-Butyl-N''-(4-methylphenylsulfonyl)urea,
SBI-0051121.P003,
AB1004876,
TL8000121,
AB00052110,
EU-0101154,
FT-0603265,
ST24031344,
ST50409552,
SW196681-3,
BIM-0051121.0001,
C07148,
D00380,
J10018,
U-2043,
AB00052110-16,
AB00052110_17,
AB00052110_18,
Tolbutamide, VETRANAL(TM), analytical standard,
I05-3340,
N-((butylamino) carbonyl)-4-methylbenzenesulfonamide,
SR-01000003059-2,
SR-01000003059-4,
SR-01000003059-7,
W-104820,
BRD-K85119730-001-06-5,
BRD-K85119730-001-17-2,
Z44591715,
Tolbutamide, European Pharmacopoeia (EP) Reference Standard,
1-(([(Butylamino)carbonyl]amino)sulfonyl)-4-methylbenzene #,
Tolbutamide, United States Pharmacopeia (USP) Reference Standard,
Diaval,
Glibenclamide,
tolbutamid-,
Orinase Diagnostic,
Tolbutamid R.A.N.,
TOLBUTAMIDE SODIUM,
Tolbutamide Pfizer Brand,
Tolbutamide Aventis Brand,
Tolbutamide Hoechst Brand,
Tolbutamide Butamide Brand,
Tolbutamide, 98% 10g,
D06OIV,
Tolbutamide sodium, sterile,
Apotex Brand of Tolbutamide,
Pfizer Brand of Tolbutamide,
Aventis Brand of Tolbutamide,
Hoechst Brand of Tolbutamide,
Butamide Brand of Tolbutamide,
Tolbutamide [BAN:INN:JAN],
R.A.N. Brand of Tolbutamide,
Valdecasas Brand of Tolbutamide,
Yamanouchi Brand of Tolbutamide,
Tolbutamide (JP15/USP/INN),
BerlinChemie Brand of Tolbutamide,
CID5505,
BZ 55,
Berlin-Chemie Brand of Tolbutamide,
C12-H18-N2-O3-S,
CS-T-44523,
Tolbutamide, 97.5% - 100G 100g,
B2194,
T3690,
D014044,
Bencenosulfonamida, n-[(butilamino) carbonil]-4-metil-,
Tolbutamide (100 - <lt/> 1,000 microg/ml) in acetonitrile,
10238-21-8,
|
| Complexity | 354 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 270.104g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 18 |
| Hydrogen Bond Acceptor Count | 3 |
| Hydrogen Bond Donor Count | 2 |
| Isotope Atom Count | 0 |
| Molecular Weight | 270.347g/mol |
| Monoisotopic Mass | 270.104g/mol |
| Rotatable Bond Count | 5 |
| Topological Polar Surface Area | 83.6A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | 2.3 |
| Symbol: | |
| Hazard Class | |
| Hazard statements | H315-H319-H335 |
| Packing Group | |
| Precautionary statements | P261-P305+P351+P338 |
| UN Code |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

